- Sectors
- Aerospace & Defense
- Big science
- Biotechnology
- Fintech
- Insights
Zen Biometrics is a venture from ARQUIMEA that aims to democratize the preventive mental healthcare.
One in three people faces extreme stress, which prolonged effects can
escalate into chronic conditions as heart disease, cirrhosis or diabetes.
Prolonged stress is not only linked to premature death, but also demonstrated to increase the risk of mental health diseases, being those considered the next global burden.
In Europe, stress-related problems cost around €280 billion annually in lost productivity and healthcare.
Cortisol, known as “the stress homone”, is the most reliable indicator for stress. Its levels rise and fall naturally throughout the day and can spike in response to stress.
Current methods to monitor cortisol levels provide measurements for one or a few time-points. But to date no technology has enabled the continuous, real-time monitoring of cortisol.
Addison’s disease, an orphan condition, represents a smaller but critically important market with critical needs. Patients with Addison’s require lifelong monitoring of their cortisol levels to manage their condition effectively and avoid potentially life-threatening adrenal crises.
The scientific community is increasingly interested in understanding the link between cortisol and various diseases. Despite this, there is currently no available method for real-time, continuous cortisol monitoring, which highlights the crucial role and unique value of our solution in improving patient care and management.